Abstract
Preoperative MRI of the breasts has been proven to be the most sensitive imaging modality in the detection of multifocal or multicentric tumor manifestations as well as simultaneous contralateral breast cancer. The aim of the presented retrospective study was to evaluate the benefit of preoperative MRI for patients with breast cancer. Preoperative MRI performed in 121 patients (group A) were compared to 225 patients without preoperative MRI (group B). Patients of group A underwent contrast-enhanced MR imaging of the breast using a 2D FLASH sequence technique (TR/TE/FA 336 ms/5 ms/90°; 32 slices of 4-mm thickness, time of acquisition 1:27 min, contrast agent dosage 0.1 mmol Gd-DTPA/kg bw). All patients had histologically verified breast cancer and follow-up for more than 20 months (mean time group A: 40.3 months, group B: 41 months). Both groups received the same types of systemic treatment after breast conserving surgery. The in-breast tumor recurrence rate in group A was 1/86 (1.2%) compared to 9/133 (6.8%) in group B. Contralateral carcinoma were detected within follow-up in 2/121 (1.7%) in group A vs. 9/225 (4%) in group B. All results were statistically significant (P<0.001). Based on these results, preoperative MRI of the breasts is recommended in patients with histopathologically verified breast cancer for local staging.
Similar content being viewed by others
References
Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225:165–175
Hlawatsch A, Teifke A, Schmidt M, Thelen M (2002) Preoperative assessment of breast cancer: sonography versus MR imaging. Am J Roentgenol 179:1493–1501
Müller-Schimpfle M, Stoll P, Stern W, Kurz S, Dammann F, Claussen CD (1997) Do mammography, sonography and MR mammography have a diagnostic benefit compared with mammography and sonography? Am J Roentgenol 168:1323–1329
Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881–888
Oellinger H, Heins S, Sander B, Schoenegg W, Flesch U, Meissner R, Felix R (1993) Gd-DTPA enhanced MRI of the breast: the most sensitive method for detecting multicentric carcinoma in female breast? Eur Radiol 3:223–226
Rieber, A, Merkle E, Böhm W, Brambs HJ, Tomczak R (1997) MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 21:773–779
Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, Callans LS, Buzby GP, Rosato EF, Fraker DL, Czerniecki BJ (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98:468–473
Early Breast Cancer Trialists’ Colloborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351:1451–1467
Early Breast Cancer Trialists’ Colloborative Group (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942
Early Breast Cancer Trialists’ Colloborative Group (1996) Ovarian ablation in early breast cancer: an overview of the randomised trials. Lancet 348:1189–1196
Fischer U (2003) Image postprocessing. In: Fischer U (ed) Practical MR mammography. Thieme, Stuttgart, pp 20–21
Baum F, Fischer U, Vosshenrich R, Grabbe E (2002) Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12:1087–1092
Fischer U, Vosshenrich R, Keating D, Bruhn H, Döler W, Oestmann JW, Grabbe E (1994) MR-guided biopsy of suspect breast lesions with a simple stereotactic add-on device for surface coils. Radiology 192:272–273
Sobin LH, Wittekind Ch (eds) (1997) UICC: TNM classification of malignant tumors, 5th edn. Wiley, New York
Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer—experience from a large study with long-term follow-up. Histopathology 19:403–410
Oh KK, Cho JH, Yoon CS, Jung WH, Lee HD (1994) Comparative studies of breast diseases by mammography, ultrasonography and contrast-enhanced dynamic magnetic resonance imaging. In: Madjar H, Teubner J, Hackelöer B-J (eds) Breast ultrasound update. Karger, Basel, pp 323–343
Boné B, Aspelin P, Bronge L, Isberg B, Perbeck L, Veress B (1996) Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 37:208–213
Soderstrom CE, Harms SE, Copit DS, Evans WP, Savino DA, Krakos PA, Farrel RS Jr, Flamig DP (1996) Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 201:427–432
Boetes C, Mus RD, Holland R, Barentsz JO, Strijk SP, Wobbes T, Hendriks JHL, Ruys SH (1995) Breast tumors. Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197:743–747
Mumtaz H, Hall-Craggs MA, Davidson T, Walmsley K, Thurell W, Kissin MW, Taylor I (1997) Staging of symptomatic primary breast cancer with MR imaging. Am J Roentgenol 169:417–424
Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE (1995) Suspect breast lesions: findings at dynamic gadolinium-enhanced MR-imaging correlated with mammographic and pathologic features. Radiology 197:387–395
Harms SE, Flamig P, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV (1993) MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187:493–501
Choi BG, Kim HH, Kim EN, Kim BS, Han JY, Yoo SS, Park SH (2002) New subtraction algorithms for evaluation of lesions on dynamic contrast-enhanced MR mammography. Eur Radiol 12:3018–3022
Walter C, Scheidhauer K, Scharl A, Goering UJ, Theissen P, Kugel H, Krahe T, Pietrzyk UI (2003) Clinical and diagnostic value of preoperative MR mammography and FDG-PET in suspicious breast lesions. Eur Radiol 13:1651–1656
Orel SG, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble BL, Torosian MH, Rosato EF (1995) Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196:115–122
Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ (2002) Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol 20:3413–3423
Roubidoux MA, Lai NE, Paramagul C, Joynt LK, Helvie MA (1996) Mammographic appearance of cancer in the opposite breast: comparison with the first cancer. Am J Roentgenol 166:29–31
Osteen RT, Connolly JL, Recht A, Silver B, Schnitt SJ, Harris JR (1987) Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. Arch Surg 122:1248–1252
Recht A, Silver B, Schnitt S, Connolly JL, Hellman S, Harris JR (1985) Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 11:1271–1276
Harris JR, Connolly JL, Schnitt SJ, Cady B, Love S, Osteen RT, Patterson WB, Shirley R, Hellmann S, Cohen RB et al (1985) The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy. Ann Surg 201:164–169
Neff PT, Bear HD, Pierce CV, Grimes MM, Fleming MD, Neifeld JP, Arthur D, Horsley JS III, Lawrence W Jr, Kornstein MJ (1996) Long-term results of breast conservation therapy for breast cancer. Ann Surg 223:709–716
Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks J, Schnitt S, Harris J (1988) Nature and extent of residual cancer in the breast related to the intraductal component in the primary tumor. Int J Radiat Oncol Biol Phys 15:182–183
Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E (1999) Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17:110–119
Hellman S (1997) Stopping metastases at their source. N Engl J Med 337:996–997
Van Thienhoven G, Voogd AC, Peterse JL et al (1999) Prognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). Eur J Cancer 35:32–38
Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L (1986) Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 57:1717–1724
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fischer, U., Zachariae, O., Baum, F. et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14, 1725–1731 (2004). https://doi.org/10.1007/s00330-004-2351-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-004-2351-z